dry needling efficacy in patients on pain and function of patient with patellofemoral pain syndrome

Not Applicable

• Conditions: patellofemoral pain syndrome.; Other soft tissue disorders related to use, overuse and pressure

• Registration Number: IRCT2016062028542N1
• Lead Sponsor: investigator

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

The inclusion criteria are: 1) reported pain of more than 6 weeks’ duration in at least two of the following situations: patellar compression, squatting, prolonged sitting, walking, stair climbing, isometric quadriceps contraction (Crossley K et al 2002; Whittingham M et al 2004; Iverson et al 2008); 2) reported pain in one of the following tests: vastus medialis coordination test, patellar apprehension test, eccentric step test (Nijs J et al 2006); 3) presence of at least one MTrP in the VMO of the symptomatic knee (pressure applied to the VMO produced pain); 4) Kujala questionnaire score between 40 and 70, and visual analog scale (VAS) score greater than 40.

Volunteers will exclud if they had a history of any of the following: ligamentous insufficiency of the knee, meniscus damage, patellar subluxation or dislocation, nerve root compression, spine or lower extremity surgery, any systemic, orthopedic or neurological disorder, or current physical therapy (Iverson CA et al. 2008; Hains G and Hains F 2010; Grindstaff TL et al 2012).

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: before treatment, 1 week after treatment, 1 month after treatment, 3 months after treatment. Method of measurement: NPRS.;PPT. Timepoint: before treatment, 1 week after treatment, 1 month after treatment, 3 months after treatment. Method of measurement: digital algometry.;Functional status. Timepoint: before treatment, 1 week after treatment, 1 month after treatment, 3 months after treatment. Method of measurement: kujala questionnaire.